Anna Kolliakou

2.7k total citations
41 papers, 1.5k citations indexed

About

Anna Kolliakou is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Anna Kolliakou has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Psychiatry and Mental health, 11 papers in Clinical Psychology and 9 papers in Pharmacology. Recurrent topics in Anna Kolliakou's work include Schizophrenia research and treatment (23 papers), Bipolar Disorder and Treatment (12 papers) and Cannabis and Cannabinoid Research (8 papers). Anna Kolliakou is often cited by papers focused on Schizophrenia research and treatment (23 papers), Bipolar Disorder and Treatment (12 papers) and Cannabis and Cannabinoid Research (8 papers). Anna Kolliakou collaborates with scholars based in United Kingdom, Italy and Ireland. Anna Kolliakou's co-authors include Robin Murray, Marta Di Forti, Anthony S. David, Valeria Mondelli, Paola Dazzan, Carmine M. Pariante, Tiago Reis Marques, Fiona Gaughran, Robert Stewart and Antonella Trotta and has published in prestigious journals such as Scientific Reports, Biological Psychiatry and Cochrane Database of Systematic Reviews.

In The Last Decade

Anna Kolliakou

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Kolliakou United Kingdom 20 820 401 293 205 175 41 1.5k
Ludovic Samalin France 25 1.2k 1.5× 525 1.3× 271 0.9× 136 0.7× 154 0.9× 111 1.9k
José M. Rubio United States 23 947 1.2× 409 1.0× 230 0.8× 272 1.3× 127 0.7× 64 1.7k
Irene Bighelli Germany 24 1.1k 1.3× 540 1.3× 232 0.8× 242 1.2× 184 1.1× 64 1.8k
Kim Donoghue United Kingdom 20 720 0.9× 311 0.8× 146 0.5× 195 1.0× 240 1.4× 45 1.4k
Olesya Ajnakina United Kingdom 21 1.0k 1.3× 480 1.2× 184 0.6× 341 1.7× 204 1.2× 55 1.9k
James Robinson United States 22 898 1.1× 533 1.3× 137 0.5× 198 1.0× 159 0.9× 34 1.9k
Brian A. Palmer United States 19 859 1.0× 646 1.6× 372 1.3× 165 0.8× 53 0.3× 44 1.7k
Pirjo Saarinen Finland 20 735 0.9× 684 1.7× 155 0.5× 129 0.6× 251 1.4× 33 1.5k
S. Leucht Germany 11 1.7k 2.1× 555 1.4× 308 1.1× 593 2.9× 186 1.1× 19 2.2k
Laila Asmal South Africa 23 1.2k 1.4× 491 1.2× 97 0.3× 315 1.5× 104 0.6× 87 1.7k

Countries citing papers authored by Anna Kolliakou

Since Specialization
Citations

This map shows the geographic impact of Anna Kolliakou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kolliakou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kolliakou more than expected).

Fields of papers citing papers by Anna Kolliakou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kolliakou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kolliakou. The network helps show where Anna Kolliakou may publish in the future.

Co-authorship network of co-authors of Anna Kolliakou

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kolliakou. A scholar is included among the top collaborators of Anna Kolliakou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kolliakou. Anna Kolliakou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
4.
Kolliakou, Anna, Ioannis Bakolis, David Chandran, et al.. (2020). Mental health-related conversations on social media and crisis episodes: a time-series regression analysis. Scientific Reports. 10(1). 1342–1342. 18 indexed citations
5.
Gaughran, Fiona, Daniel Ståhl, Dominic Stringer, et al.. (2019). Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study. The British Journal of Psychiatry. 215(6). 712–719. 21 indexed citations
8.
Ajnakina, Olesya, Antonella Trotta, Marta Di Forti, et al.. (2018). Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients. Psychiatry Research. 269. 199–206. 32 indexed citations
9.
Jackson, Richard, Rashmi Patel, Anna Kolliakou, et al.. (2017). Natural language processing to extract symptoms of severe mental illness from clinical text: the Clinical Record Interactive Search Comprehensive Data Extraction (CRIS-CODE) project. BMJ Open. 7(1). e012012–e012012. 154 indexed citations
11.
Ajnakina, Olesya, John Lally, Marta Di Forti, et al.. (2017). Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis. Schizophrenia Research. 193. 391–398. 9 indexed citations
12.
Lally, John, Olesya Ajnakina, Marta Di Forti, et al.. (2016). Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. Psychological Medicine. 46(15). 3231–3240. 217 indexed citations
13.
Colizzi, Marco, Elena Carra, Sara Fraietta, et al.. (2015). Substance use, medication adherence and outcome one year following a first episode of psychosis. Schizophrenia Research. 170(2-3). 311–317. 54 indexed citations
14.
Bianconi, Francesca, M. Bonomo, Arianna Marconi, et al.. (2015). Differences in cannabis-related experiences between patients with a first episode of psychosis and controls. Psychological Medicine. 46(5). 995–1003. 22 indexed citations
15.
Colizzi, Marco, Conrad Iyegbe, John Powell, et al.. (2015). Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophrenia Bulletin. 41(5). 1171–1182. 57 indexed citations
16.
Falcone, M. Aurora, Robin Murray, B. Wiffen, et al.. (2014). Jumping to Conclusions, Neuropsychological Functioning, and Delusional Beliefs in First Episode Psychosis. Schizophrenia Bulletin. 41(2). 411–418. 60 indexed citations
17.
Wiffen, B., Jennifer O’Connor, Manuela Russo, et al.. (2013). Do Psychosis Patients with Poor Insight Show Implicit Awareness on the Emotional Stroop Task?. Psychopathology. 47(2). 93–100. 10 indexed citations
18.
Forti, Marta Di, Conrad Iyegbe, Hannah Sallis, et al.. (2012). Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users. Biological Psychiatry. 72(10). 811–816. 169 indexed citations
19.
Marques, Tiago Reis, Shubuladè Smith, Stefania Bonaccorso, et al.. (2012). Sexual dysfunction in people with prodromal or first-episode psychosis. The British Journal of Psychiatry. 201(2). 131–136. 40 indexed citations
20.
Stilo, Simona A., Marta Di Forti, Valeria Mondelli, et al.. (2012). Social Disadvantage: Cause or Consequence of Impending Psychosis?. Schizophrenia Bulletin. 39(6). 1288–1295. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026